D&A at other companies
Other financials
Where this comes from
Reported directly by TuHURA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about TuHURA Biosciences, Inc.'s d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TuHURA Biosciences, Inc.'s D&A?
- TuHURA Biosciences, Inc. (HURA) reported D&A of $23.47K in Q1 2026.
- How has TuHURA Biosciences, Inc.'s D&A changed year-over-year?
- TuHURA Biosciences, Inc.'s D&A increased by 67.0% year-over-year, from $14.06K to $23.47K.
- What is the long-term trend for TuHURA Biosciences, Inc.'s D&A?
- Over 2 years (2023 to 2025), TuHURA Biosciences, Inc.'s D&A has grown at a -36.6% compound annual growth rate (CAGR), from $177.38K to $71.27K.
- What does D&A mean?
- Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.